B. Braun Recalls Specific Streamline Bloodline Sets Over Risk of Detachment and Leaks
On October 27, 2026, FDA MedWatch issued an early alert regarding a medical device recall by B. Braun. The company is recalling specific lots of its Streamline Bloodline Set for Dialog+, a tubing set used during hemodialysis treatment. B. Braun notified affected customers on October 20, 2026, instructing them to stop using, quarantine, and return the impacted devices. The issue stems from an unperformed solvent application step during assembly, which leaves the dialyzer connector improperly bonded. This defect can cause the tubing connector to detach or leak during dialysis. Patients undergoing hemodialysis could experience serious blood loss, blood clotting, or air entering their bloodstream. As of October 10, 2026, B. Braun had not received any reports of serious injuries or deaths tied to the defect. The FDA is currently reviewing information about the issue. Customers and healthcare providers should check inventory for impacted lot numbers A2600099, A2600128, and A2600136.
What was announced
The FDA MedWatch Safety Alerts program published an alert about a recall of B. Braun Streamline Bloodline Sets for the Dialog+ system. Model SL-2010M2096 is affected, specifically lot numbers A2600099, A2600128, and A2600136.
During manufacturing, workers omitted a required solvent application step. Without this step, the dialyzer connector is not adequately bonded to the tubing. B. Braun mailed a letter to customers on October 20, 2026, recommending that facility staff and distributors immediately remove affected items from use or sale, isolate them, and return them to the manufacturer.
What it means
The Streamline Bloodline Set moves blood outside the body during hemodialysis. Because the connector may not be fully attached, the arterial tubing could leak or separate while a patient receives treatment.
Separation of the bloodline can lead to immediate blood loss or cause blood to clot inside the tubing circuit. Patients might need emergency medical interventions, additional treatments, or hospitalization. If the connection loosens, air can also enter the blood tubing. Dialysis machines contain air detectors that normally alert staff, but if air passes through, it can cause an air embolism or death. As of October 10, 2026, B. Braun reported no serious injuries or deaths. Users with affected inventory can contact B. Braun by email at recalls@bbraunusa.com or by phone at (610) 849-1197.
What the announcement does not tell us
The alert does not state how many individual units or devices are included across the three affected lots. It also does not explain how the missing solvent application step occurred or why internal quality checks did not catch the error before distribution.
Furthermore, the announcement does not give a timeline for when replacement bloodline sets will reach affected facilities. The FDA noted it is reviewing the device issue, but the agency has not specified when it will finish its review or issue a final recall classification.
How this was written
This analysis was written with AI from the official announcement below, using only facts that announcement states. The quoted wording is FDA MedWatch Safety Alerts’s own. Always check the original before acting on anything here.
The dialyzer connector may not be attached appropriately, resulting in leaking and potential blood loss.
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.